Müller Jörg Andreas, Delank Karl-Stefan, Laudner Kevin, von Rüsten Anne, Schneider Constanze, Selig Jessica Isabel, Wittenberg Ian, Zeh Alexander, Vordermark Dirk, Medenwald Daniel
Department of Radiation Oncology, University Hospital Halle (Saale), Halle (Saale), Germany.
Department of Orthopedics, Trauma, and Reconstructive Surgery, University Hospital Halle (Saale), Halle (Saale), Germany.
Front Oncol. 2025 May 29;15:1555502. doi: 10.3389/fonc.2025.1555502. eCollection 2025.
Sarcomas represent a heterogenous group of neoplasms, and there is a lack of data describing treatment patterns in Germany. The specific aim of this study was to evaluate treatment strategies and therapeutic outcomes of extremity sarcoma based on German cancer registry data.
From 2000 to 2023, we identified n=3,094 patients diagnosed with extremity sarcoma from the German clinical cancer registries of Brandenburg-Berlin, Saxony and Saxony-Anhalt. Using logistic regression and Cox-proportional hazard analysis, we determined predictors of overall survival (OS). Propensity-score matching (PSM) was used to balance covariates and to reduce potential bias. We included sex, age at diagnosis, tumor localization, histological grade, Eastern Cooperative Oncology Group (ECOG) performance status, T-status and treatment as parameters in our regression models. To assess the robustness of our findings in the presence of missing data, we conducted a sensitivity analysis using multiple imputation.
A total of 2,240 propensity score-matched patients with extremity sarcomas were included. In multivariable Cox regression, higher age, high tumor grade, and advanced T-status were significantly associated with increased mortality. Treatment with radiotherapy (RT) alone was linked to worse survival (HR 1.82, 95% CI 1.12-2.95, = 0.015), whereas neoadjuvant RT and surgery alone showed no survival advantage compared to adjuvant RT. The median OS was longest for patients treated with surgery alone (194 months) and adjuvant RT (146 months), and shortest with RT alone (82 months). Sensitivity analyses using multiple imputation confirmed the robustness of the results.
Adjuvant RT and surgery alone were associated with the most favorable survival outcomes in patients with extremity sarcomas. Advanced age, tumor grade, and T-stage were strong negative prognostic factors. RT without surgery was linked to significantly reduced survival.
肉瘤是一组异质性肿瘤,德国缺乏描述治疗模式的数据。本研究的具体目的是基于德国癌症登记数据评估肢体肉瘤的治疗策略和治疗结果。
2000年至2023年,我们从勃兰登堡-柏林、萨克森和萨克森-安哈尔特的德国临床癌症登记处识别出n = 3094例被诊断为肢体肉瘤的患者。使用逻辑回归和Cox比例风险分析,我们确定了总生存期(OS)的预测因素。倾向评分匹配(PSM)用于平衡协变量并减少潜在偏差。我们将性别、诊断时年龄、肿瘤定位、组织学分级、东部肿瘤协作组(ECOG)体能状态、T分期和治疗作为回归模型的参数。为了评估在存在缺失数据的情况下我们研究结果的稳健性,我们使用多重填补进行了敏感性分析。
总共纳入了2240例倾向评分匹配的肢体肉瘤患者。在多变量Cox回归中,年龄较大、肿瘤分级高和T分期晚期与死亡率增加显著相关。单纯放疗(RT)治疗与较差的生存率相关(HR 1.82,95% CI 1.12 - 2.95,P = 0.015),而新辅助放疗和单纯手术与辅助放疗相比没有生存优势。单纯手术治疗的患者中位OS最长(194个月),辅助放疗患者为146个月,单纯放疗最短(82个月)。使用多重填补的敏感性分析证实了结果的稳健性。
辅助放疗和单纯手术在肢体肉瘤患者中与最有利的生存结果相关。高龄、肿瘤分级和T分期是强烈的负面预后因素。无手术的放疗与生存率显著降低相关。